Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PULM: Bigggggggggg dip to $3........... added 5k shares here
That was uncalled for.
CMON Nowwwwwwwwwwwwwwwwwww
GO $PULM
Yes, the Analyst's Target price is $30 per share! In fact its recent high was $61!
This Hidden Gem (PULM) will soar the Same 5.2-Bagger to $16.458 very soon as its Bio-Tech peer (PBHG: from $0.0005 to $0.0026) did most recently...
If PULM matches the Same performance with its NASDAQ peer (TBLT: from $1.34 to $9.589) then it will hit $22.6487!
10x++ soon enough
Shorts are hitting it hard. Shares are being loaned out today.
First the shake then the bake, something serios about to happen here…
Little shakeout/retest going on here - opened with a gap up, not unexpected hour-in action -- yet the fuse has been lit
$PULM
Especially with some sort of material news / bigger implications...
With only 3.1 million shares in the public float PULM could be a rocket!
You may be right. SI has shrunk to all time lows. The big boys know something is going down
Parralax (4.5billion dollar medical/biotech hedge fund) now owns 27%, as of 6/31 due to recent filing -- potentially through confidential filing acquisition? Some other entity may have taken a large >5% position on 8/5, due to that volume spike.
PUR1800 P1B Data publication soon - which will open doors to IPF/Chronic indications, and re-entrance of JnJ partnerships?
Lots of other *ongoing* catalysts that could hit, such as Oexia, Nocion, other licenses/partnerships.
Think the company is ready and funds are supporting the effort for a big pop, just my opinion.
Jumped 65 cents yesterday; today 259K shares pre market, up .75...
can't find news anywhere on why...
buyout?
breakthrough?
partnership?
iSPERSE is King, Multi+billion dollar company in the making, imo. ??
Pulmatrix 3 Current Pipeline Items :
1) PUR1800 (AECOPD): $2.4B Peak U.S. Rev, JNJ, Kinase Inhibitors + New Indications (IPF, Lung Cancer)
**P1B Results being prepared for data publication on chronic dosing indications - *potential near-term catalyst events*
2) PUR1900 (ABPA): Pulmazole - $1.5B Peak Rev in U.S., 50/50 CIPLA Partnership, Expansion opportunity globally & across indications, 'become new standard of care' through reducing limiting side effects on increased oral Itraconazole usage.
*P2B Starting in '23, FDA Fast Tracked, FDA Type-C Reviewed
3) PUR3100 (Migraine):
$575M
U.S. Market; Applying iSPERSE onto previous
$1B
allergen purchase of MAP004 (failed for safety)
*P1 Trials completing around now; P2 & P3 planned for 2023
And the bonus of royalty streams from FEND (PUR003/006) creating the 'air hygiene' category.
Pipeline can expand quickly with iSPERSE being applied to already in-use/developed standards of care of novelty formulations, yielding improved patient care.
$PULM
$3000 reverse split adjusted
HA~!
Yes, The Analyst's Target price is $30 a share!
Wow, Huge Cash Value --- $20.232 a share!
Wow, Huge Book Value --- $18.878 a share!
100% Wrong Info.! The Analyst's Target price is $30 (=$1.5 x 20) and the most recent highs were $21 and $15.6 respectively!
In fact its recent high was $31.8 which is 6%-Higher than the Analyst's Target price $30!
So PULM is at Hyper Oversold status --- from $31.8 to $4.831!
PULM is also Super Undervalued now based on both Huge Book Value ($18.878) And Huge Cash Value ($20.232)!
It will be very easy for PULM to run the Same 5.2-Bagger Quick rally like its peer (PBHG: from $0.0005 to $0.0026) did most recently to create a New 52-week-high $25.1212 (current one is $23.4)!
Wrong, read stocktwits thread for more info on pricetargets.
the old 5$ is the new 100$
raised to 10$ wich is the new 200$
wich you can find at certainly 5 places now.
If you find 10$ its calculated before split.
There has never been a 5$ pt analyst after split,so.
this is the way it is:)
Yes, the Analyst's Target price is $30 and the most recent highs were $21 and $15.6!
In fact the 52-week-high was $31.8 which is 6%-Higher than the Analyst's Target price $30!
PULM is at Hyper Oversold status!
PUL is also Super Undervalued now based on both Huge Book Value ($18.878) And Huge Cash Value $20.232)!
yep knew that was lurking
I sold 170K shares @ .40 for a -$7500 loss, if I had held, would have been worse
I still regret holding like I did...
I followed some Twitter group leader in here, company did 2 offerings back to back then an RS
ugh, this turd never bounced like many thought it could
reminds me of MULN
Pulmatrix announces 1-for-20 reverse stock split, effective Mar.1
Stinks to hear - check back in 2 months from now...
Think you missed the timing big time here.
Always another ticker in the market though.
I lost about -$7500 on PULM
sold 170K shares @ .40
but hey I could have held like a Dodo bird
Vote for no RS will stick. Extend the Nasdaq compliance. Nothing will happen with the stock price anytime soon.
Big day tomorrow. What is everyone's prediction on RS?
MM's keep walking it down to increase the RV size.
bastards
MMs buried this stock for a reason slowly walking it down to collect shares and/or maximize rev split
When is the reverse split?
pulm
onary
$65M+ cash and all this? Just waiting to erupt.
PUR1800 Data (which will validate iSPERSE) + 2.4Billion U.S. market for AECOPD
PUR3100 P1/P2 Trial Start - which will validate iSPERSE in taking a previously $800M acquired failed P3 (b/c of safety) formulation to market.
FEND - Beginning of marketing campaign & wildcards with WHO, CDC, Next Breath, and beyond - coming out party coming soon.
PUR1900 (Pulmazole) - FDA Fast Trac, QIDP Status, and partnered with India's largest inahlation company -- looking for other news ahead of 2023 here (LPAD?)
Nocion Partnership - At some point they will look to bring in iSPERSE into their formulations - which are in P2 moving to P3.
JnJ Partnership - At some point, won't be surprised to see JnJ re-enter on PUR1800 for long-term dosage of Lung Cancer.
Oxeia Partnership - Given Ted Raad just joined their BoD, and they have iSPERSE mentioned in a patent - wouldn't be surprised to see something.
iSPERSE as a Platform = $$$
$PULM
yep~!
lost good $$$ on PULM turd
2 offerings back to back then an R/S
no wonder im ready to retire
Last evening PULM bounced up to $0.45! I'm wondering if it will test the most recent high $0.469 as soon as today? $0.78 will be hit again in the coming days/weeks anyway...
PULM turned out to be a POS...
$PULM This is going to rip so hard...
Yes management likely to issue a bit more additional stock options/etc. -- yet on a weighted average basis of available employee compensation, the vast majority of shares have already been issued & vested at much higher levels ($1.25-$1.35 level).
And don't discount Ted's 1.2million option position at a strike price of $1.35. $100 stock price implying a 10billion valuation = $100M payday for Ted Raad. I can all but guarantee you he is not interested in just being in the money at ~$3-$5, he's looking for a big big payout too for his effort.
Why am I throwing around $100 stock price with ease? Well remember - PUR1800 AECOPD US market alone is $2.4B Revenue in peak year (5-7 years out?). Implying a $5B market capitalization with 15% EBITDA and 15x Multiple on such. And this is just one indication, in one market...
Fun and games nearing an end - big revaluation higher coming in Q1 2022.
$0.4 will be broken down very soon! Which means we won't see any price higher than $0.8 in the future!
I know. But on-going Super Heavy Diluting crashed this Huge Diluting Pos Scam to $0.4 from this-month-high $0.7799!
So we should see at least a couple of more New lows until it hits $0.38...
I'm glad to have sold all my shares at $0.45 ~ $0.44 this early morning! I'll buy them back at $0.38 ~ $0.42. Currently I just bought some shares at $0.42 and ready to sell them at $0.45 or higher price levels.
hmmmmmm...interesting! Cash @$1.11 per share vs. $0.40 pps.
Source: Page F-3, December 31, 2020 PULM 10-k.
As I predicted exactly PULM finally crashed to $0.4 today from its most recent high $1.05 (which was created in the after-hour session)!
So this hidden gem is currently at Hyper Oversold status --- from $1.05 to $0.4!
The diamond-in-rough is also Super Undervalued now!
I'm taking my first position $0.40xx today because I believe the Real Bottom is very closing by $0.4. Let's see if any Good News will push it back to $0.86 ~ $1.04 again since the analyst's target is $1.5!